These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 9316688)
1. Felbamate pharmacology and use in epilepsy. Burdette DE; Sackellares JC Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688 [TBL] [Abstract][Full Text] [Related]
2. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Palmer KJ; McTavish D Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493 [TBL] [Abstract][Full Text] [Related]
3. Felbamate: a new antiepileptic drug. Wagner ML Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890 [TBL] [Abstract][Full Text] [Related]
4. Is there any future for felbamate treatment? Borowicz KK; Piskorska B; Kimber-Trojnar Z; Małek R; Sobieszek G; Czuczwar SJ Pol J Pharmacol; 2004; 56(3):289-94. PubMed ID: 15215558 [TBL] [Abstract][Full Text] [Related]
5. [Felbamate: perspectives for new antiepileptic treatment]. Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622 [TBL] [Abstract][Full Text] [Related]
6. Felbamate: clinical and molecular aspects of a unique antiepileptic drug. Brown WM; Aiken SP Crit Rev Neurobiol; 1998; 12(3):205-22. PubMed ID: 9847055 [TBL] [Abstract][Full Text] [Related]
7. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration. Taylor LA; McQuade RD; Tice MA Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Felbamate Study Group in Lennox-Gastaut Syndrome N Engl J Med; 1993 Jan; 328(1):29-33. PubMed ID: 8347179 [TBL] [Abstract][Full Text] [Related]
12. Felbamate overdose: a case report and discussion of a new antiepileptic drug. Nagel TR; Schunk JE Pediatr Emerg Care; 1995 Dec; 11(6):369-71. PubMed ID: 8751173 [TBL] [Abstract][Full Text] [Related]
13. Felbamate: successful development of a new compound for the treatment of epilepsy. Schmidt D Epilepsia; 1993; 34 Suppl 7():S30-3. PubMed ID: 8243376 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience. Shah YD; Singh K; Friedman D; Devinsky O; Kothare SV Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692 [TBL] [Abstract][Full Text] [Related]
15. Advances in the pharmacotherapy of epilepsy. Ramsay RE Epilepsia; 1993; 34 Suppl 5():S9-16. PubMed ID: 8339715 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of felbamate in therapy for partial epilepsy in children. Carmant L; Holmes GL; Sawyer S; Rifai N; Anderson J; Mikati MA J Pediatr; 1994 Sep; 125(3):481-6. PubMed ID: 8071763 [TBL] [Abstract][Full Text] [Related]
17. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial. Dodson WE Epilepsia; 1993; 34 Suppl 7():S18-24. PubMed ID: 8243374 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of felbamate. Corradetti R; Pugliese AM Life Sci; 1998; 63(13):1075-88. PubMed ID: 9763203 [TBL] [Abstract][Full Text] [Related]
19. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview]. Steinhoff BJ Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894 [TBL] [Abstract][Full Text] [Related]